A5092438369- COVID-19 Clinical Research Studies
- COVID-19 and healthcare impacts
- Lipoproteins and Cardiovascular Health
- Heart Failure Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Diabetes Treatment and Management
- Cardiac pacing and defibrillation studies
- Chronic Disease Management Strategies
- Pharmaceutical Economics and Policy
- Pharmaceutical Practices and Patient Outcomes
- Long-Term Effects of COVID-19
- COVID-19 Impact on Reproduction
- SARS-CoV-2 and COVID-19 Research
- Cardiovascular Function and Risk Factors
- Potassium and Related Disorders
- Pancreatic function and diabetes
- Cardiac Health and Mental Health
Universidad Autónoma de Occidente
2024-2025
Heart failure (HF) is one of the leading causes morbidity and mortality worldwide. This study aimed to assess impact sex on sociodemographic, clinical, laboratory parameters in patients with HF who were included Colombian Failure Registry (RECOLFACA).
Introduction Viral infection by SARS-CoV2 is a pandemic affecting over 600 million people worldwide. One of five hospitalized patients may present myocardial injury, strongly associated with disease severity and mortality. Methodology Retrospective cross-sectional study COVID-19 diagnosed between May 01, 2020, June 30, 2021, from the database Registro Latinoamericano de Enfermedad Cardiovascular y (CARDIO COVID 19–20) troponin value recorded during hospitalization. A descriptive analysis...
Heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF) has differences in therapy and development when compared HF EF (HFrEF). We aimed to describe the clinical characteristics all-cause mortality of patients HFpEF/HFmrEF those HFrEF from Colombian Failure Registry (RECOLFACA). RECOLFACA included adult ambulatory recruited 2017 2019. All-cause was our main outcome. used Kaplan-Meier method, life table, Cox proportional hazard models evaluate role comorbidities on...
Abstract Background Primary cardiac lymphoma (PCL) involves the heart almost exclusively although it can extend to surrounding structures including pericardium. Most PCLs in adults are of B-cell origin and its signs symptoms generally non-specific depend on location size. In general, cancer patients usually have a slim chance receive transplantation (OHT), it’s not an absolute contraindication depending decision multidisciplinary team experience each institution. Case Presentation A...
The COVID-19 pandemic has highlighted a correlation between cardiac complications and elevated biomarkers, which are linked to poorer clinical outcomes.
Cardiovascular disease (CVD) represents the primary cause of death and disability globally, with elevated cholesterol as one leading risk factors for CVD. We describe clinical characteristics, treatment patterns, effectiveness evolocumab in treating hyperlipidemia. Observational study conducted through a chart review patients hyperlipidemia receiving part management Colombia. This included 115 treated evolocumab. A total 101 (87.8%) had history CVD, 13 (11.3%) familial hypercholesterolemia...
Cardiovascular disease (CVD) represents the primary cause of death and disability globally, with elevated cholesterol as one leading risk factors for CVD. We describe clinical characteristics, treatment patterns, effectiveness evolocumab in treating hyperlipidemia. Observational study conducted through a chart review patients hyperlipidemia receiving part management Colombia. This included 115 treated evolocumab. A total 101 (87.8%) had history CVD, 13 (11.3%) familial hypercholesterolemia...
The value of Sodium-glucose cotransporter-2 inhibitors (SGLT-2 inhibitor) therapy in individuals with heart failure preserved EF (HFpEF) was unknown until the EMPEROR-Preserved trial. We aimed to assess proportion patients HFpEF that are eligible for empagliflozin within Colombian Heart Failure Registry (RECOLFACA).